📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Novel drugs approved by the EMA, the FDA, and the MHRA in 2023: A year in review. (2024)

First Author: Papapetropoulos A

Attributed to: Investigating lactate as an inflammatory early signal in ectopic lymphoid neogenesis and its translational impact in patients with autoimmune diseases funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1111/bph.16337

PubMed Identifier: 38519837

Publication URI: http://europepmc.org/abstract/MED/38519837

Type: Journal Article/Review

Volume: 181

Parent Publication: British journal of pharmacology

Issue: 11

ISSN: 0007-1188